ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NextCure, Inc. - Common Stock (NQ:NXTC)

7.750 +1.020 (+15.16%)

Streaming Delayed Price Updated: 3:42 PM EDT, Aug 12, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	363,353
Open	6.750
Bid (Size)	7.720 (100)
Ask (Size)	7.800 (500)
Prev. Close	6.730
Today's Range	6.600 - 7.940
52wk Range	1.550 - 15.74
Shares Outstanding	2,676,110
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Get insights into the top gainers and losers of Friday's after-hours session. ↗

August 07, 2026

Via Chartmill

NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results

August 06, 2026

From NextCure

Via GlobeNewswire

Performance

YTD	-41.6%	-41.6%
1 Month	+255.5%	+255.5%
3 Month	-20.8%	-20.8%
6 Month	-36.7%	-36.7%
1 Year	+61.5%	+61.5%

More News

Top movers in Tuesday's session ↗

August 04, 2026

Via Chartmill

Halper Sadeh LLC is Investigating Whether VEEE, NXTC, TCBK, FHB are Obtaining Fair Deals for their Shareholders

July 23, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders

July 21, 2026

From Ademi LLP

Via GlobeNewswire

In today's session, these stocks are experiencing unusual volume. ↗

July 16, 2026

Via Chartmill

These stocks are moving in today's after hours session ↗

July 15, 2026

Via Chartmill

Unusual volume stocks are being observed in Wednesday's session. ↗

July 15, 2026

Via Chartmill

Wednesday's pre-market session: top gainers and losers ↗

July 15, 2026

Via Chartmill

NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders

July 14, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Kartoon Studios (NYSE: TOON) Enters Catalyst-Rich Growth Phase

July 14, 2026

Via AB Newswire

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

July 14, 2026

Via Chartmill

Power Moves: NXTC, TOON, SHPH, COCH Entry Points Ignite on Major Catalysts

July 14, 2026

Via AB Newswire

Discover the most active stocks in Tuesday's session. ↗

July 14, 2026

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 14, 2026

Via Benzinga

NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders

July 14, 2026

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 14, 2026

Via Benzinga

NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

July 14, 2026

From NextCure

Via GlobeNewswire

NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers

June 04, 2026

From NextCure

Via GlobeNewswire

NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026

June 01, 2026

From NextCure

Via GlobeNewswire

NextCure Provides Business Update and Reports First Quarter 2026 Financial Results

May 07, 2026

From NextCure

Via GlobeNewswire

NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers

May 04, 2026

From NextCure

Via GlobeNewswire

NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026

April 21, 2026

From NextCure

Via GlobeNewswire

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

April 07, 2026

From NextCure

Via GlobeNewswire

NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026

March 31, 2026

From NextCure

Via GlobeNewswire

Frequently Asked Questions

Is NextCure, Inc. - Common Stock publicly traded?

Yes, NextCure, Inc. - Common Stock is publicly traded.

What exchange does NextCure, Inc. - Common Stock trade on?

NextCure, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NextCure, Inc. - Common Stock?

The ticker symbol for NextCure, Inc. - Common Stock is NXTC on the Nasdaq Stock Market

What is the current price of NextCure, Inc. - Common Stock?

The current price of NextCure, Inc. - Common Stock is 7.750

When was NextCure, Inc. - Common Stock last traded?

The last trade of NextCure, Inc. - Common Stock was at 08/12/26 03:42 PM ET

What is the market capitalization of NextCure, Inc. - Common Stock?

The market capitalization of NextCure, Inc. - Common Stock is 20.74M

How many shares of NextCure, Inc. - Common Stock are outstanding?

NextCure, Inc. - Common Stock has 21M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.